Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Clinical trial NCT04803201 · RECRUITING

Trial details

NCT number: NCT04803201
Sponsor: Alliance for Clinical Trials in Oncology
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Angioimmunoblastic T-cell Lymphoma Enteropathy-Associated T-Cell Lymphoma Follicular T-Cell Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma Nodal Peripheral T-Cell Lymphoma With TFH Phenotype Peripheral T-Cell Lymphoma, Not Otherwise Specified

Start date: 2021-10-08
Primary completion: 2027-05-19
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.